US equities sold off sharply on Thursday as the “AI scare trade” widened, sending the major averages lower while investors rotated defensively and raised cash ahead of key inflation data reading or CPI.
Today in the Markets – Thursday, Feb. 12, 2026…
McDonald’s (MCD) has handled low-carb fads, kale revolutions, and the brief reign of cauliflower rice, but its newest rival comes with a prescription label and a co-pay. GLP-1 weight-loss medicines—from injectables like Eli Lilly’s (LLY) Mounjaro and Zepbound to the next wave…
Meta’s decision to plant a more-than-1-gigawatt data center in Lebanon, Indiana, reads like a statement that the future of AI won’t be confined to Silicon Valley ZIP codes. The planned campus, with over $10 billion in investment, is set to become one…
AST SpaceMobile (ASTS) is dialing up its next phase of growth with a $1.0 billion private offering of convertible senior notes due 2036, aiming to finance a truly out-of-this-world ambition: building the first space-based cellular broadband network directly accessible by standard smartphones.…
Wall Street finished Wednesday essentially unchanged, as a hotter‑than‑expected January jobs report lifted Treasury yields and tempered hopes for imminent Fed rate cuts, leaving the major indexes little moved by the close. in
Index performance
Dow Jones Industrial Average: Fell roughly 70…
US stocks extended last week’s relief rally on Monday, with megacap tech doing most of the heavy lifting while value names tried to remember what outperformance felt like. Investors spent the session toggling between AI euphoria, tariff anxiety and a yield curve…
Eupraxia Pharmaceuticals (NASDAQ: EPRX) may still wear the “clinical-stage” name tag, but its stock has been behaving like it already found a seat at the grown‑ups’ table on Wall Street. Over the past year, shares have climbed roughly 160%, far outpacing the…
Eli Lilly (LLY) has once again muscled its way to the top of the healthcare league tables, with its stock climbing as investors double down on the idea that obesity drugs are less a fad and more a new asset class. The…
Wall Street closed the week ending Feb. 6, 2026 looking a bit like a trader after a rough options expiry: bruised, but suddenly energetic once the bell rang on Friday. The Dow finally cracked the 50,000 mark in a more-than-1,000‑point sprint, while…
Modular Medical’s (NASDAQ: MODD) Pivot insulin delivery system is quietly building a credible bull case that now extends beyond regulatory momentum and leadership credentials into hard operational execution. With the company achieving a key manufacturing milestone for its Pivot tubeless insulin patch…
